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Coxsackievirus type B (CVB) infection of the pancreas induces a massive cellular infiltrate composed of natural killer cells,
T cells, and macrophages and leads to the destruction of exocrine tissue. The physiological manifestations of pancreatic CVB
infection are correlated with viral tropism; the virus infects acinar cells but spares the islets of Langerhans. Here we evaluate
the mechanisms underlying pancreatic inflammation and destruction and identify the determinants of viral tropism. T-cell-
mediated immunopathology has been invoked, along with direct virus-mediated cytopathicity, to explain certain aspects of
CVB-induced pancreatic disease. However, we show here that in the pancreas, the extent of inflammation and tissue
destruction appears unaltered in the absence of the cytolytic protein perforin; these findings exclude any requirement for
perforin-mediated lysis by natural killer cells or cytotoxic T cells in CVB3-induced pancreatic damage. Furthermore,
perforin-mediated cytotoxic T-cell activity does not contribute to the control of CVB infection in this organ. In addition, we
demonstrate that the recently identified coxsackie-adenovirus receptor is expressed at high levels in acinar cells but is barely
detectable in islets, which is consistent with its being a major determinant of virus tropism and, therefore, of disease.
However, further studies using various cell lines of pancreatic origin reveal secondary determinants of virus tropism. © 2000
Academic Press
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iINTRODUCTION
Coxsackieviruses are members of the Picornaviridae
family and lie in the Enterovirus genus, along with polio-
viruses, echoviruses, and unclassified enteroviruses.
Coxsackieviruses are classified, according to their
pathogenicity in newborn mice, into groups A and B,
which consist of 24 and 6 serotypes, respectively. Type B
coxsackieviruses (CVB) are common human pathogens
and have been implicated in acute and chronic myocar-
ditis, pancreatitis, and myositis, among other diseases.
CVB infection in the mouse faithfully recapitulates many
of the aspects of several human diseases, such as the
clinical and histological features of myocarditis (Wood-
ruff and Woodruff, 1974; Woodruff, 1979; Henke et al.,
1995; Knowlton et al., 1996; Huber et al., 1999) and the
establishment of chronic infection in the absence of
functional B cells (Mena et al., 1999). In addition, CVB
infection of mice frequently causes a severe pancreatitis
(reviewed in Ramsingh, 1997).
The pancreas has exocrine and endocrine functions. The
bulk of the organ is composed of exocrine tissue, consist-
ing of collections of acini that produce digestive enzymes.
The islets of Langerhans, embedded sporadically through-
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276out the acinar tissue, constitute the endocrine pancreas
and contain a, b, and d cells (secreting glucagon, insulin,
and somatostatin, respectively). Enteroviruses, and espe-
cially CVB, have been implicated in 20–34% of human pan-
creatitis cases (Arnesjo et al., 1976; Ozsvar et al., 1992), and
n animal models, there is unequivocal proof that CVB
auses pancreatitis. CVB replicates to high titers in the
ouse pancreas, and localization studies have identified
irus in acinar cells but not in islets (Ross et al., 1974;
uorinen et al., 1989; Vella et al., 1991) by immunohisto-
hemistry (Vella et al., 1992; Arola et al., 1995) and by in situ
ybridization (Vuorinen et al., 1989; Vella et al., 1991; Arola et
l., 1995). There is acinar cell destruction and immune
nfiltration, both of which vary depending on the virus (Cag-
ana et al., 1993) and the host genetic background (Ram-
ingh et al., 1989). A role for CVB has been suggested in
hildhood-onset insulin-dependent diabetes mellitus
IDDM; Clements et al., 1995; reviewed in Ramsingh et al.,
997), but CVB-induced IDDM has not been convincingly
emonstrated in humans and is an extremely infrequent
esult of infection of normal animals. Thus CVB infection
auses pancreatitis, but the relationship between CVB in-
ection and IDDM is more tenuous. The clinical conse-
uences of infection are consistent with the viral distribu-
ion in the pancreas: acinar involvement with sparing of the
slets. The reason for this tropism has not been previously
stablished, and we investigate this issue here.
In addition to establishing the reason for acinar cell
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277PATHOGENESIS OF COXSACKIEVIRUS PANCREATITIStropism, we clarify the mechanism underlying acinar cell
destruction. It is clear that CVB, like most picornaviruses,
can be a highly cytolytic agent, but in many virus infec-
tions, much of the tissue damage results not from virus-
mediated lysis but rather from immune-mediated (immu-
nopathological) cell death. Commonly, the immunopa-
thology results from lysis of infected cells by virus-
specific CD81 cytotoxic T lymphocytes (CTL), which act
by releasing perforin to disrupt the membrane of the
target cell or by inducing target cell apoptosis via the Fas
pathway. We have found that abrogation of the perforin
pathway can greatly reduce the myocarditis that follows
CVB infection, indicating that in the heart, immunopathol-
ogy plays a dominant part in tissue damage (Gebhard et
al., 1998). Elegant studies by others have implicated the
immune response in pancreatic disease (Ramsingh et
al., 1999), and here we investigate the contribution of
perforin-mediated lysis to CVB-induced pancreatitis and
acinar cell destruction. In summary, the data presented
here show (1) the role of perforin-mediated lysis in CVB3-
induced pancreatic disease; (2) the role of the CVB re-
ceptor in determining pancreatic tropism of the virus and
of the resulting physiological manifestations of disease,
and (3) the presence of ancillary factors, other than
receptor expression, that may protect islet cells from
infection.
RESULTS
Viral distribution during the course of CVB infection
To better evaluate the relationship between pancreatic
pathology and virus titers, we first established the kinet-
ics of CVB infection in various tissues. C57BL/6 mice
T
Summary of CVB Kinetics in V
Days p.i. Serum Spleen Heart
0.5 22 22 22
1 12 12 12
2 11 11 11
3 11 11 11
4 112 111 111
5 122 111 111
7 22 12 12
14 22 22 12
23 22 22 22
Note. Mice were infected with 500 PFU CVB3 i.p., and at each of the n
or infectious CVB3. The results are summarized above. At each time p
ouse; 1 indicates that virus was detected in the tissue; 2 indicates
ndicated by the number of symbols in each box of that row; two mice
ere analyzed at days 4 and 5. Note that at the later time points (day 1
re known to have been successfully infected because at 3 days p.i.,
rom the mice in Table 1 are presented in Fig. 1.were infected intraperitoneally with 500 PFU of CVB3,
and at each time point indicated in Table 1, mice weresacrificed and viral titers were measured in various or-
gans and tissues as shown. Virus was detectable in the
pancreas, liver, and feces as early as 12 h postinfection
(p.i.), in the absence of detectable viremia. The early
appearance of virus in these locations, all of which are
associated with the gastrointestinal tract, confirms the
strong tropism of this enterovirus, even when adminis-
tered intraperitoneally. Virus was present in all tissues
between days 2 and 4 and in the great majority of tissues
on day 5; titers were highest in most tissues on day 2 or
3 p.i. (not shown). Viremia declined by day 4 or 5 p.i.,
coincident with the appearance of high titers of neutral-
izing antibody (S. Harkins, data not shown) and was
absent by day 7, although virus remained detectable in
other organs at this time point. By 14 days p.i., virus was
detectable only in the heart, and by 23 days p.i., virus
could not be detected in any organs.
Histological, physiological, and biochemical
consequences of pancreatic CVB infection
The consequences of CVB infection of the pancreas
have been described by others (Vuorinen et al., 1989),
most often using CVB4 (Ramsingh et al., 1997, 1999;
Ramsingh, 1997). To evaluate the consequences of
CVB3-induced pancreatitis, we used several criteria, as
summarized in Fig. 1. As stated above, the peak of
viremia occurs at days 2–3 p.i., and virus is undetectable
in the serum by 7 days p.i. Several changes occur coin-
cident with peak viral titers. First, animals become se-
verely hypoglycemic; the normal blood glucose level (120
mg/dl) drops by almost half. Concurrently, marked eleva-
tions of serum pancreatic enzymes (amylase and lipase)
Tissues After i.p. Inoculation
ces Pancreas Liver Small intestine
2 12 12 22
1 12 12 12
1 11 11 11
1 11 11 11
11 111 111 111
11 111 111 111
2 12 11 12
2 22 22 22
2 22 22 22
icated time points, mice were sacrificed, and their tissues were titrated
ch 1 and 2 symbol represents the CVB titer in the tissues of a single
rus was not detected. Thus the number of mice at each time point is
assayed at each time point on days 0.5–3 and days 7–23; three mice
3), virus was not detectable in the tissues of several mice; these mice
d been present in their feces and/or serum. Additional data obtainedABLE 1
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278 MENA ET AL.lose approximately 30% of their body weight by day 7 p.i.
In addition to these biochemical and physiological
changes, marked histopathological changes, including
acinar cell destruction, were noted beginning at day 2 p.i.
Severe inflammation and acinar cell destruction occur
in the absence of perforin-mediated CTL or natural
killer (NK) cell activity
Acinar cells may be lysed in at least two ways: (1) by
direct virus-mediated cytolysis or (2) by immune-medi-
ated destruction of infected cells. Because CD81 T cells,
which are predominantly CTL, have been identified in the
pancreatic infiltrate after CVB infection (Ramsingh et al.,
1997) and antibody depletion of these cells diminishes
mortality rates (Ramsingh et al., 1999), it was suggested
that CD81 T cells might contribute to the disease pro-
ess. We have previously demonstrated that CTL play an
mportant immunopathological role in CVB-induced myo-
arditis; mice lacking perforin have reduced inflamma-
ory infiltrate, very little acute myocardial damage, and
inimal long-term sequelae (Gebhard et al., 1998). To
xplore the role of perforin-mediated lysis in acinar cell
estruction, we infected perforin knockout (PKO) mice
ith CVB and evaluated the pancreatic pathology at
FIG. 1. Summary of signs associated with CVB-induced pancreatitis
isease, including elevated serum levels of the pancreatic enzymes lipa
lucose levels (, far right y-axis), and the presence of Ca21 precipitat
including acinar cell destruction and immune infiltration) were evaluat
In all cases, the numerical values (body weight, blood glucose, and viru
Two mice failed to display pancreatitis (one at day 4, one at day
“prepancreatitis” levels. Beyond this time point, data are presented froeveral time points p.i. The results are presented in Fig.
, where they are compared with results in immunocom-etent (perforin1) mice. Strikingly, the acinar tissue in
oth strains of mouse shows pathological changes as
arly as 2 days p.i. (Figs. 2A and 2G). Interstitial edema,
egranulation, and loss of the characteristic eosinophilic
taining occurred throughout the acinar tissue, with
ome mononuclear infiltration. By 10 days p.i., there is
assive infiltration and acinar cell destruction, and duc-
al metaplasia is seen, both in normal mice and in PKO
ice (Figs. 2B and 2H). The inflammatory changes re-
ain in both strains at day 14 p.i. (Figs. 2C and 2I).
herefore, extensive inflammation and acinar cell death
ccur even in the absence of perforin; we conclude that
n contrast to our findings in myocarditis, perforin-medi-
ted lysis by CTL or by NK cells is not required for
VB-induced pancreatitis and tissue damage.
Pancreatic ducts and islets of Langerhans appeared
ormal at all time points examined in both mouse strains,
onsistent with the absence of hyperglycemia, which
uggests that the islets are performing their physiologi-
al function. During our analyses of pancreatic pathol-
gy, we noted macroscopic nodules on the peritoneum
nd in the retroperitoneal space adjacent to the pan-
reas in both perforin1 and PKO mice. Histological anal-
ysis was consistent with fat necrosis, with deposition of
ce shown in Table 1 were evaluated for several criteria of pancreatic
amylase (Enz), percent loss of body weight (M, first right y-axis), blood
e peritoneum/retroperitoneal space. In addition, histological changes
l mice. Viremia (F, left y-axis) is included as an indication of viral titer.
) are presented as the arithmetical means of values in individual mice.
a from all mice are included before day 2 p.i. to provide baseline
ice in which pancreatitis was histologically evident.. All mi
se and
es in th
ed in al
s titerscalcium salts, which can be identified by von Kossa’s
stain (Fig. 2D). Fat necrosis and deposition of calcium
optosi
d eosi
279PATHOGENESIS OF COXSACKIEVIRUS PANCREATITISsalts in the peritoneum can also occur in human pancre-
atic disease, sometimes resulting in lesions sufficiently
large to be detectable by noninvasive techniques (Gooby
Toedt et al., 1996). In addition, infected cells may undergo
apoptosis. Therefore, we sought evidence for apoptotic
cells in the pancreas; as shown, (Fig. 2E), apoptosis was
detected in acinar tissue undergoing destruction but was
absent from the islets and from the ductal structures that
appear in response to pancreatic tissue injury.
Perforin is not required for control of pancreatic CVB
infection
Although the absence of CTL had no effect on the
degree of inflammation or tissue destruction (Fig. 2), it
was possible that the lack of perforin-mediated lysis
might have resulted in higher virus titers in the pancreas.
To test this hypothesis, PKO mice and their perforin1
littermates were infected with CVB, and viral titers were
measured. As shown in Fig. 3, titers at day 4 were very
similar in both genotypes, and at day 9, most mice had
cleared the infection. Comparison of the CVB pancreatic
titers in the presence or absence of perforin (Fig. 3)
revealed no statistically significant difference at day 4 p.i.
(P 5 0.49) or at day 9 p.i. (P 5 0.39). In summary, the data
FIG. 2. Pancreatic destruction during CVB3 infection does not require
immunocompetent (perforin-positive) mice, and panels G–I are from PKO
infected at the following times before harvest: panels A and G, 2 days; B
stain (detecting calcium precipitates), and panel E shows staining for ap
and Methods). All other panels represent staining with hematoxylin anin Figs. 2 and 3 show that in the pancreas, as in the heart
(Gebhard et al., 1998), perforin plays no detectable role inlimiting CVB replication. However, in contrast to our find-
ings in the heart, perforin is not required for extensive
pancreatic destruction. Our findings suggest that much
of the acinar cell lysis may be directly virus mediated and
demonstrate that if immunopathology plays a role in
pancreatic pathology, it does not require the perforin
pathway.
Viral tropism in the pancreas correlates with
expression of the putative virus receptor
One of the most striking features of CVB infection of
the pancreas is the sparing of islets even during periods
of intense inflammatory response and acinar cell de-
struction, and as previously reported by others, the virus
is localized in acinar cells but not in islets (Vuorinen et
al., 1989; Vella et al., 1991, 1992; Arola et al., 1995). We
wanted to determine the reason for this cell-specific
tropism, and we therefore used in situ hybridization to
evaluate receptor expression in the infected pancreas.
First, we confirmed that the tropism of CVB3 was as
previously reported for various CVB isolates; as shown in
Fig. 4A, almost all acinar cells are infected, whereas
connective tissue, ducts, and islets appear free of virus
signal. A higher-power magnification (Fig. 4B) clearly
n-mediated lysis by CTL or NK cells. As indicated, panels A–F are from
Panel F shows an uninfected pancreas. All other panels are from mice
H, 10 days; and panels C, D, and I, 14 days. Panel D shows von Kossa’s
s (cells containing fragmented DNA are stained deep brown; Materials
n.perfori
mice.
, E, anddisplays the sparing of islets. Next, we evaluated expres-
sion of mouse coxsackie-adenovirus receptor (mCAR),
280 MENA ET AL.the proposed receptor for both coxsackieviruses and
adenoviruses (Bergelson et al., 1997, 1998; Tomko et al.,
1997). We carried out in situ hybridization studies of the
pancreas using an mCAR probe. Low-power fields are
shown in Figs. 4C and 4D and reveal a uniformly dense
signal in acinar tissue, interrupted by islets (Fig. 4C) and
ducts (Fig. 4D). A higher-power field, with a shorter in situ
hybridization exposure, is shown in Fig. 4E. There is
extensive mCAR signal in acinar tissue, but very little
signal, if any, is present in the central islet. As a control,
the adjacent tissue section was probed with the opposite
sense mCAR probe; no signal is seen (Fig. 4F). As a
formal control to prove that islet cell mRNA could be
detected by in situ hybridization, pancreatic tissue was
probed for insulin mRNA expression. As shown in Fig.
4G, the insulin signal in an uninfected pancreas was very
strong and specific to islets. Finally, we evaluated insulin
expression in an infected pancreas in which there is
extensive acinar cell loss (Fig. 4H). Consistent with the
biochemical data (absence of diabetes), the frequency
and signal intensity of islets were indistinguishable from
those observed in uninfected pancreas. Taken together,
these data show clearly that virus tropism (Figs. 4A and
4B) correlates well with mCAR expression (Fig. 4C–4E).
FIG. 3. Perforin is not required for control of pancreatic CVB3 infec-
tion. PKO mice, and their perforin-positive littermates, were infected
with 500 PFU CVB3, and at 4 and 9 days p.i., mice were sacrificed and
the viral titers in the pancreata were measured. Each group, at each
time point, has five or six mice. Data are shown for individual mice, and
for each group, the mean is indicated. Statistical comparisons of
perforin1 and PKO groups at each time point failed to identify signifi-
cant differences (day 4, P 5 0.49; day 9, P 5 0.39).We next wanted to further dissect the relationship, in
pancreatic cells, between mCAR expression and sus-ceptibility to CVB infection to identify the roles of the CVB
receptor(s) and to determine whether other cellular at-
tributes might contribute to viral tropism. Because such
experiments cannot be easily carried out in vivo, we
turned to analyses of three pancreatic cell lines, each
derived from a different pancreatic progenitor; Panc02
cells are said to be of ductal origin (Corbett et al., 1984);
266-6 cells are of acinar origin, and NIT-1 cells are
derived from an insulinoma. HeLa cells (on which the
virus is titrated) were included as a control cell line.
Evaluation of mCAR and decay accelerating factor
(DAF) expression in pancreatic cell lines
We first evaluated expression of CAR mRNAs by re-
verse transcription–polymerase chain reaction (RT–PCR)
(Fig. 5). The primers used for mCAR mRNA amplification
also were homologous to the human CAR (hCAR) se-
quences, and as expected, hCAR mRNA was easily de-
tectable in HeLa cells. mCAR mRNA is readily detected
in 266-6 (acinar) cells but cannot be detected in NIT-1
(insulinoma) cells; this correlates well with the in vivo
viral distribution presented in Fig. 4. The identification of
mCAR in the Panc02 cell line was unexpected, given the
FIG. 4. In situ hybridization analyses of CVB, mCAR, and insulin
expression. RNA probes are used throughout, and their specificities
are indicated to the left of the figure. Panels A and B show low and high
magnifications of a CVB3-infected pancreas (2 days p.i.) probed for
positive-sense (genomic) CVB RNA. Virus is present in the acinar tissue
but not in islets or ducts. Panels C–E are probed with negative-sense
RNA complementary to mCAR and show mCAR expression in unin-
fected acinar cells; C and D are different low-power fields, showing
lack of mCAR expression in islets and a large duct, respectively. Panels
E and F are adjacent sections, but F is probed with the opposite sense
RNA. Panels G and H are probed for insulin mRNA; G is uninfected
pancreas, and H is 6 days p.i.
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281PATHOGENESIS OF COXSACKIEVIRUS PANCREATITISapparent absence of mCAR expression from ductal cells
in vivo (Fig. 4). It is possible that the Panc02 cell line is,
in fact, not of ductal origin, because the cellular origins of
pancreatic carcinomata are difficult to determine (Long-
necker et al., 1992), and ductlike carcinomata can arise
from tumors of acinar origin (Pettengill et al., 1993). We
lso analyzed expression of mRNA encoding DAF, which
ay act as a coreceptor for CVB3 (Shafren et al., 1995,
997a; Agrez et al., 1997; Martino et al., 1998). Expression
f DAF mRNA was detected only in HeLa and 266-6 cells
Fig. 5). The different sizes of RT–PCR product most likely
epresent differentially spliced DAF mRNA messages
Caras et al., 1987). DAF mRNA remained undetectable in
anc02 and NIT-1 cells even after 10 additional cycles of
CR amplification (not shown). As a positive control for
ur RT–PCRs, we used primers for the “housekeeping”
RNA GAPDH; this messenger was readily detected in
ll four cell lines. Finally, to confirm that the NIT-1 cell line
ad maintained some of the characteristics of an insuli-
oma, we evaluated insulin mRNA expression therein;
he RNA was detectable in this cell line but in none of the
emaining three.
roductive infection of pancreatic cell lines after CVB
nfection or RNA transfection
We next determined whether the pancreatic acinar, duc-
al, and islet cell lines could be productively infected. Cells
ere incubated with CVB3 (m.o.i. 5 5), and 10 h later,
upernatants were harvested and titrated. As shown in Fig.
A, there is a 105-fold range in virus yield, from high (HeLa
cells, ;108/ml) to very low (NIT-1 cells, 103/ml). Control
experiments, designed to identify any residual input virus
that might contribute to plaque formation, indicated that
such virus would generate a maximum of 103 plaques (not
shown). Thus the plaques detected from the insulinoma
line NIT-1 may represent residual input virus rather than
FIG. 5. mCAR and DAF mRNA expression in pancreatic cell lines. On
analyzed by RT–PCR for expression of mRNAs specific for CAR, DAF, GA
gel electrophoresis, and bands were visualized using ethidium bromidprogeny. To determine whether the resistance to infection
was dictated solely by receptor expression, we evaluatedthe capacity of these cell lines to support productive infec-
tion after transfection of full-length infectious CVB RNA,
thus circumventing the requirement for receptor binding/
cell entry. After transfection, HeLa and Panc02 cells appear
similar in their production of infectious virus (Fig. 6B). Con-
trol experiments indicated that unlike residual input virus,
residual input RNA could not be transferred in the super-
natant to contribute to the formation of plaques on the
indicator cells, and therefore the few plaques (,3 3 103/ml)
roduced by 266-6 and NIT-1 cell lines do reflect low-level
roduction of infectious progeny, albeit at yields ;100-fold
elow those from HeLa and Panc02 cells.
orrelation between mCAR and DAF expression, and
VB RNA synthesis in pancreatic cell lines
The above data evaluate the susceptibility of the cell
ines to infection at the population level. To evaluate
nfection at the single-cell level, we used a little-used
an (HeLa) and three murine (Panc02, 266-6, and NIT-1) cell lines were
nd insulin. After 30 cycles of PCR, samples were separated by agarose
FIG. 6. Viral titers after infection (A) or transfection of pancreatic cell
lines (B). The three murine pancreatic cell lines, along with HeLa cells,
were either incubated with 5 3 105 PFU CVB3 (m.o.i. 5 0.5) (A) ore humtransfected with 5 mg of infectious CVB RNA (B). Ten hours later, the
supernatants were harvested and titrated for infectious virus.
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282 MENA ET AL.technique, fluorescent in situ hybridization (FISH)–fluo-
rescent activated cell sorter (FACS) (Cao et al., 1995),
which we modified to our needs. In this procedure, cells
FIG. 7. FISH-FACS analysis of CVB RNA levels in individual cells of
four cell lines. The four indicated cell lines were incubated with CVB3
(m.o.i. 5 10), washed, and supplied with fresh medium. Then 6 h later,
the cells were fixed and incubated under ISH conditions with a biotin-
ylated RNA probe specific for the genomic strand of CVB3. After
washing to remove unbound probe, the cells were incubated with
streptavidin-PE, washed, and analyzed on a flow cytometer. The y-axes
indicated fluorescence (arbitrary units), whereas the x-axis indicates
cell size.
T
Summary
HeLa
control
RT-PCR
CAR 1
DAF 1
Infectivity (pfu/ml) in supernatant after:
Incubation with virusa 108
RNA transfectionb ;105
FISH-FACS
Infected cells (%) 97.5
MFIc 1.4 3 10
Note. CAR and DAF expression data are taken from Fig. 5. The infe
a 5 bwith 5 3 10 PFU CVB3 or transfection with 5 mg of RNA. FISH-FACS data
c Mean fluorescence intensity (MFI) is shown for cells that scored positivewere incubated with virus and, 6 h later, were fixed and
incubated with a biotinylated RNA probe specific for the
target RNA (in this case, genomic CVB). After washing,
the cells were incubated with streptavidin-PE and then
analyzed on an FACS machine. Fluorescent cells, which
contain viral RNA, were readily identified. As shown in
Fig. 7, almost 100% of HeLa cells exposed to CVB
showed fluorescence ;100-fold higher than background.
This signal is derived from newly synthesized CVB RNA,
rather than from input viral RNA, because it first appears
4 h after infection (not shown). In contrast, the insulinoma
cell line NIT-1 showed no evidence of infection, consis-
tent with the in vivo sparing of islets. Because HeLa cells
are CAR1 and NIT-1 cells are CAR2, it is tempting to
suggest that the difference in fluorescence is determined
by CAR expression. However, only a small proportion of
the mCAR1 cell lines Panc02 and 266-6 contained CVB
RNA. Experiments are under way to determine why only
a subpopulation of each of these cell lines was suscep-
tible to CVB infection. The data from the in vitro analyses
are summarized in Table 2 and are discussed below.
DISCUSSION
Common causes of human pancreatitis include alco-
hol and other toxins, gallstones, acquired or congenital
structural defects, and metabolic diseases. However,
;25% of cases of adult and childhood pancreatitis have
been classified as idiopathic (Weizman and Durie, 1988;
Lankisch et al., 1996), and it is likely that a significant
roportion of these are infectious in origin. Bacteria,
ungi, protozoa, and viruses all can cause human pan-
reatitis (Parenti et al., 1996), but it is clear that entero-
iruses, and CVB in particular, are strongly associated
ith this disease. Several independent studies have in-
icated that viral involvement is relatively common. In
ne report, 34% of patients with acute or chronic pancre-
titis showed significant elevation of CVB-specific anti-
Line Data
Panc02
ductal
266-6
acinar NIT-1 islet
1 1 2
2 1 2
3 3 105 104 103
;105 ;2 3 103 ;2 3 103
7.3 5 2
9.5 3 102 3.6 3 102 2
ata are taken from Fig. 6. Infectious titers are shown after incubationABLE 2
of Cell
3
ctivity d
are from Fig. 7.
in the assay.
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283PATHOGENESIS OF COXSACKIEVIRUS PANCREATITISbody titers (Ozsvar et al., 1992), and a second study
revealed evidence of enteroviral infection in 20% of pa-
tients with acute pancreatitis (Arnesjo et al., 1976). In this
study, we analyzed CVB-induced pancreatitis in the
mouse model, focusing on the factors that determine the
specific targeting of virus-induced pathology to the aci-
nar tissue. We set out to address several questions. How
much of the acinar destruction is virus mediated, and
how much is immunopathological? In the latter case,
which effector components of the immune response are
involved? What determines the cellular tropism that re-
sults in such exquisite susceptibility of acinar cells but
nonpermissiveness of the islets?
We show that in C57BL/6 mice, which are relatively
resistant to CVB3-induced myocarditis, CVB3 infection
results in severe acinar pancreatitis. The resulting pa-
thology is restricted to the acinar cells, judging by both
physiological (Fig. 1) and histological (Fig. 2) parameters.
These data mirror the findings of other researchers (cited
previously), who used different strains of CVB and of
mice, and thus suggest that pancreatitis is a frequent
consequence of CVB infection; this reflects the situation
in humans, in which all six CVB serotypes have been
associated with pancreatitis (B3–B5, Capner et al., 1975;
B1/B6, Lal et al., 1988; B5, Gooby Toedt et al., 1996; B2,
B3, and B5, as well as several echoviruses, Arnesjo et al.,
1976), and one case has been described that is sugges-
tive of father-to-daughter transmission of CVB5-induced
pancreatitis (Ursing, 1973). A careful study evaluating the
role of the MHC locus indicated that all mouse strains
studied developed pancreatitis, albeit of varying degrees
(Ramsingh et al., 1989). It has been suggested that the
pancreas serves as the primary site of CVB3 replication
and that the severity of myocarditis is determined (at
least in part) by pancreatic virus titers (Gomez et al.,
1991). However, in the present study, we see little myo-
carditis, despite high CVB3 pancreatic load, indicating
that any such relationship is indirect.
The mechanism by which CVB infection results in
extensive pancreatic damage has not been determined.
Several possibilities have been proposed, including a
direct cytopathic effect and immune-mediated destruc-
tion of the infected cells. Immune-mediated destruction
is supported by the observation that the MHC class I
background of the mouse influences the severity of
CVB4-induced pancreatitis (Ramsingh et al., 1989), and
recent interesting studies using immunocompromised
mice revealed maximal tissue damage at the peak of the
inflammatory response, rather than at the peak of viral
titers (Ramsingh et al., 1999); from this it was inferred that
the immune response probably played a role in pancre-
atic disease. We have previously identified a strong re-
quirement for perforin in CVB-induced myocardial infil-
tration and damage (Gebhard et al., 1998), and here we
have evaluated whether a similar requirement exists in
the pancreas. In contrast to the heart, we find little
d
tevidence for perforin-mediated immunopathology in the
pancreas and suggest that the extensive pancreatic in-
flammatory infiltrate seen at later time points may be the
result of massive acinar cell death, rather than its cause.
A direct viral cytolytic effect is suggested by the appear-
ance, coincident with peak viral titers, of histopathology
and of pancreatic enzymes in the blood (Fig. 1). Clinical
signs (release of pancreatic enzymes, hypoglycemia) are
seen at early time points, when there is extensive virus
infection (Fig. 4) but little infiltration (Fig. 2). Moreover, no
beneficial effects of perforin ablation are seen; the in-
flammatory response remains brisk in PKO mice, and
extensive acinar destruction is seen (Fig. 2). These data
demonstrate that any immunopathological component of
pancreatic destruction does not require perforin-medi-
ated lytic activity. Apoptosis is seen, but it is not clear
whether this is virus induced or the consequence of
fas-FasL contact between infected acinar cells and T
cells. The marked difference in immunopathology in the
heart and the pancreas indicates that as observed in
other model systems (Tay and Welsh, 1997), the conse-
quences of antiviral immunity may vary dramatically in
different organs of the infected host. This is not merely of
academic interest. We have suggested (Gebhard et al.,
1998) that temporary blockade of the perforin pathway
might be beneficial in the treatment of CVB myocarditis,
but the present findings suggest that such therapy would
probably be ineffective in limiting pancreatic disease.
The data also shed some light on the immune mech-
anisms involved in control and eradication of CVB. We
(Henke et al., 1995) and others (Woodruff and Woodruff,
1974; Woodruff, 1979) have shown that CD81 T cells play
some role in regulating CVB titers, but we found that
perforin-mediated cytolysis was not required for viral
clearance from the heart (Gebhard et al., 1998). We there-
fore suggested that the antiviral effect in the heart was
more likely mediated by interferon-g, released by virus-
specific CD81 T cells. Here we show that CVB titers in
the pancreata of PKO mice are essentially indistinguish-
able from those in normal mice (Fig. 3), demonstrating
that perforin-mediated lysis plays no part in controlling
viral levels in this organ. The importance of interferon-g
in protecting against CVB-induced pancreatitis has re-
cently been demonstrated, although the cellular source
of this cytokine was not identified (Horwitz et al., 1999).
inally, the role of the innate immune response must not
e ignored; mice deficient in nitric oxide synthase show
ncreased pancreatic necrosis and elevated viral titers,
onsistent with nitric oxide playing a protective role in
ombating CVB infection of the pancreas (Zaragoza et
l., 1999).
As shown by others and here (Figs. 4A and 4B), the
reat majority of acinar cells showed very strong CVB-
pecific hybridization signal, whereas it was minimal in
ucts and islets. The intensity of the signal, along with
he high viral titers observed in the pancreas (up to 5 3
284 MENA ET AL.1010 PFU/g tissue), not only indicates that acinar cells
support a highly productive infection but also underlines
the nonpermissive nature of islet cells, which escape
infection despite being bathed in a pool of virus for
several days. We observe hypoglycemia (inconsistent
with IDDM) and weight loss. Thus our data provide no
support for the hypothesis that CVB causes IDDM. It has
been suggested that in the viral population (quasispe-
cies), there are variants with tropism for the islet cells
(Yoon et al., 1978). Our observations (along with those of
other researchers) suggest that in a normal infection, the
generation of a viral variant with islet tropism is ex-
tremely rare. However, could nongenetic modifications
alter the tropism of virus generated in the pancreas,
rendering it capable of infecting islet cells? Picornavirus
maturation requires autolytic cleavage of the viral
polyprotein; viral progeny from the enzyme-rich acinar
pancreas could have infectivity characteristics different
from viral progeny from other tissues, as has been de-
scribed for reovirus (Nibert et al., 1991). We compared
virus grown in HeLa cells with virus obtained from pan-
creas 3 days p.i. but found no difference in their tropism
(i.e., in their ability to infect various different cell lines,
including the insulinoma line NIT-1) or in their sensitivity
to neutralization by polyclonal rabbit antiserum (data not
shown).
Why are acinar cells infected, while islets are spared?
This outcome has been noted for other CVB strains and
in different murine hosts. We sought to determine
whether this tropism corresponded to a differential ex-
pression of the putative viral receptor(s). CVB is known to
interact with at least two cell-surface proteins. First to be
identified was decay-accelerating factor (DAF), a regula-
tory component of the complement pathway; homologs
have been identified in mice (Harris et al., 1999) and men
(Caras et al., 1987). More recently, a second protein was
shown to bind both CVB and adenoviruses; homologs of
this CAR have been found in mice (mCAR) and in hu-
mans (hCAR) (Bergelson et al., 1997, 1998; Tomko et al.,
1997). However, we have recently shown that B lympho-
cytes are infected in vivo despite lacking detectable
mCAR expression (Mena et al., 1999), and the relation-
ship between DAF/CAR expression and susceptibility to
infection is complex, even under easily monitored tissue
culture conditions. For example, some CVB3 isolates
bind to DAF, whereas others do not (Bergelson et al.,
1995), depending on key amino acids in the VP2 protein
(Shafren et al., 1997a). Several studies have evaluated
the requirement for DAF binding of the cardiovirulent
CVB3 strain Nancy (the strain used in the present study);
most reports have shown that DAF plays an important
role as a primary receptor (Agrez et al., 1997; Shafren et
al., 1997a; Martino et al., 1998), but one study stated that
this virus did not bind to DAF-transfected cells (Bergel-
son et al., 1995). Our understanding of the role of CAR is
also incomplete. It has been suggested that DAF acts asthe initial receptor, or sequestration site, from which the
virus might be “transferred” to CAR, for cell entry (Shafren
et al., 1997a), but deletion of the cytoplasmic and trans-
membrane regions of CAR does not diminish its ability to
facilitate CVB infection, suggesting that the role of CAR
may be in virus binding, rather than in cell entry (Wang
and Bergelson, 1999). Proteins other than CAR have
been proposed as potential recipients of DAF-bound
enteroviruses; one study identified intercellular adhesion
molecule-1 as a coreceptor (Shafren et al., 1997b), and a
second implicated integrin aVb6 (Agrez et al., 1997). This
imperfect correlation between cellular permissiveness
and receptor expression also exists in vivo; we have
shown that the mouse spleen, with very low to undetect-
able levels of expression of mCAR, supports a high load
of virus during the acute infection, and that B lympho-
cytes are infected in vivo in the absence of readily de-
tectable expression of mCAR (Mena et al., 1999). There-
fore, although it has been stated that all coxsackievi-
ruses tested so far use CAR as a cellular receptor (Wang
and Bergelson, 1999), we suggest that under certain
circumstances, CVB can infect cells in vivo in a CAR-
independent manner. Interestingly, CAR-independent ad-
enoviruses have been recently identified (Hidaka et al.,
1999). However, in the present study, there is a good
correlation between mCAR expression in vivo and sus-
ceptibility to CVB infection. mCAR mRNA levels are much
higher in acinar cells than in islets, and the latter are
resistant to CVB infection.
To investigate the factors that determine pancreatic
cell susceptibility/resistance to CVB3 infection in a more
controlled situation, we obtained three cell lines originat-
ing from murine pancreatic carcinomata: one line of
apparent ductal origin, another of acinar origin (secreting
pancreatic enzymes), and the third was an insulinoma.
The relationships among receptor expression, produc-
tion of infectious virus after infection or transfection, and
intracellular RNA levels are summarized in Table 2. After
incubation with CVB, only the NIT-1 cell line lacks de-
tectable intracellular RNA and fails to produce infectious
progeny; this corresponds well with the lack of CAR and
DAF expression on these cells. NIT-1 cells produce only
low quantities of virus after RNA transfection, suggesting
that the absence of receptor may be only one of several
barriers protecting islets in vivo. HeLa and Panc02 cells
are similar in their ability to produce infectious virus after
RNA transfection but differ markedly in virus yield after
incubation with infectious virus. Both cell lines express
CAR (albeit, one is hCAR and the other is mCAR), but only
HeLa cells express DAF. It is possible that the lack of
DAF on Panc02 cells contributes to the low susceptibility
of these cells to infection, because anti-DAF antibodies
have been shown to block CVB binding and entry into
HeLa cells (Martino et al., 1998). The complexity of CVB–
receptor interactions further refutes the notion that every
virus must have one, and only one, receptor. The concept
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285PATHOGENESIS OF COXSACKIEVIRUS PANCREATITISof one (or more) coreceptors applies to several viruses,
including HIV (Alkhatib et al., 1996; Berger et al., 1999),
and has important ramifications for our understanding of
viral pathogenesis and for the development of antiviral
therapies and vaccines.
MATERIALS AND METHODS
Cells and virus
The HeLa cells used for the preparation of viral stocks
and for plaque assays were a kind gift from Dr. Rainer
Wessely (University of California at San Diego) and were
maintained in Dulbecco’s modified Eagle’s medium
(DMEM; GIBCO BRL, Gaithersburg, MD) supplemented
with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100
U/ml penicillin, and 100 mg/ml streptomycin (complete
MEM). Cell line Panc02, derived from a C57BL/6 pan-
reatic carcinoma (Corbett et al., 1984), was purchased
from the Frederick Cancer Research Facility and main-
tained in RPMI 1640 (GIBCO BRL) plus 10% FBS. Cell
lines NIT-1 and 266-6 were both purchased from the
American Type Culture Collection (Rockville, MD). NIT-1
cells are derived from a spontaneous insulinoma in
NOD/Lt mice and retain expression of insulin. This cell
line was maintained in medium F-12K (GIBCO BRL) plus
10% FBS, as recommended by the supplier. The 266-6
cells originate from a pancreatic acinar cell tumor exper-
imentally induced in (C57BL/6 3 SJL) F1 mice and retain
expression of a number of digestive enzymes. These
cells were maintained in complete DMEM. Viral stocks of
the myocarditic Nancy strain of CVB3 were obtained from
plasmid pH3, kindly provided by Dr. Kirk Knowlton (Uni-
versity of California at San Diego). This plasmid contains
the complete cDNA of the viral genome (Knowlton et al.,
1996) and yields infectious virus when transfected into
HeLa cells.
Mice
Male mice ($10 weeks old) were used for all of the
experiments described. C57BL/6 mice were purchased
from The Scripps Research Institute breeding facility.
Mice heterozygous at the perforin locus were generously
provided by Drs. Craig Walsh and Bill Clark (University of
California at Los Angeles). These perforin62 mice were
interbred, and the genotypes of the progeny were deter-
mined by PCR. In this way, homozygous negative (PKO)
mice were obtained, along with 1/1 and 62 littermates;
thus the outcome of infection in PKO mice could be
compared with the outcome in perforin1 littermates, min-
mizing any possible effect of genetic background.
iochemical and histological evaluations
Immediately before infection, body weight was re-
orded, and blood glucose level was measured in a drop
f blood from the tail vein with an AccuChek Advantageonitor (Boehringer-Mannheim Biochemicals, Indianap-
lis, IN). Mice were then inoculated intraperitoneally with
.4 ml of serum-free DMEM containing 500 PFU of virus.
ody weight and blood glucose levels were recorded
gain at the time of sacrifice. Feces samples were snap
rozen in liquid nitrogen for viral titrations, and mice were
acrificed by anesthesia overdose (halothane). From
ach mouse, serum samples were frozen and used later
or viral titration. Analysis of amylase and lipase levels in
erum samples was performed by Biomedical Testing
ervices (San Diego, CA). Pancreas, spleen, and heart
ere divided into two parts; one was frozen in liquid
itrogen for later titration, and the other was fixed in 10%
eutral buffered formalin (NBF) and embedded in paraf-
in for histological and in situ hybridization studies. Liver
nd small intestine samples also were prepared for viral
itrations. Calcium deposits were macroscopically evi-
ent and were fixed in 10% NBF for histological analysis.
poptosis was evaluated using the ApoTag kit according
o the instructions of the manufacturer (Oncor, Gaithers-
urg, MD). Apoptotic cells exhibit deep brown staining.
iral titration
Feces samples were weighed and disaggregated in
00 ml of DMEM containing 100 U of penicillin and 100
mg of streptomycin, and debris was cleared by centrifu-
gation. Organ samples were weighed and subsequently
homogenized in 1 ml of serum-free DMEM. Serial dilu-
tions of feces and organ/serum samples were titrated on
HeLa monolayers, as previously described (Mena et al.,
999).
reparation of RNA and RT–PCR
Total RNA from organs (liver and spleen) and from
issue-culture cells was obtained using TRIZOL Reagent
GIBCO BRL) and the conditions recommended by the
anufacturer. Total RNA (5 mg) was used as template for
he synthesis of first-strand cDNA using oligo(dT) as
rimer and RT Superscript II (GIBCO BRL). Then 5% of the
T reaction was used in a PCR with the following sets of
rimers: for the detection of CAR, 59-GGCGCGCCTACT-
TGCTTCG-39 and 59-CACTGGTCAGAGCCCACTCTG-39;
or mouse DAF, 59-CGGAGACTGCGGCCCACC-39 and 59-
CGACTAGCCTGTACCC-39; for insulin, 59-ATGGCCCT-
TGGATGCGC39 and 59-GCAGTAGTTCTCCAGCTGG-39;
nd for GAPDH, 59-CCATCACCATCTTCCAGGAG-39 and
9-CCTGCTTCACCACCTTCTTG-39. The amplified cDNA
or insulin (from mouse pancreas RNA) was cloned and
sed for the transcription of a specific RNA probe for in
itu hybridization (see below).
reparation of 33P-labeled and biotin-labeled RNA
probesRNA probes for in situ hybridization (ISH) and FISH
were transcribed in vitro from linearized plasmids con-
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286 MENA ET AL.taining CVB3, mCAR, or insulin sequences. Plasmid
mCAR2, containing the full coding sequence of mCAR,
was a kind gift of Dr. J. M. Bergelson (Philadelphia, PA).
Either [a-33P]UTP (Amersham, Arlington Heights, IL) or
iotin-16-UTP (Boehringer-Mannheim) was included in
he transcription reaction, and the probes were purified
hrough a ChromaSpin 30 column (Clontech, Palo Alto,
A).
SH
The protocol followed for ISH, using 5-mm paraffin
ections, has been published previously (Lane et al.,
997). After prehybridization at 42°C, sections were al-
owed to hybridize overnight at 45°C with 2 3 106 to 5 3
06 cpm of 33P-labeled probe. After washing, slides were
dipped in photographic emulsion and stored in the dark
at 4°C for 2–5 days, after which they were developed and
fixed, then stained with hematoxylin (3–5 min) and eosin
(2 min), and mounted.
CVB3 infection in pancreas-derived cell lines
Cells were grown on 6-well plates until they were
;70–80% confluent. At this time, medium was aspirated
and replaced with 400 ml of DMEM containing 5 3 105
PFU CVB3 (m.o.i. 5 ;0.5). Plates were then held at 37°C
in a CO2 incubator for 2 h, after which the monolayers
were washed twice with DMEM and covered with either
(1) 3 ml of agarose-DMEM mix (to determine whether the
cell lines supported plaque formation) or (2) 1 ml of
complete DMEM. Plates with agarose/DMEM were in-
cubated for an additional 38 h and then fixed and stained
with crystal violet to identify plaques. Plates with liquid
medium were incubated for 8 h (total of 10 h since
infection, sufficient time to permit one full replicative
cycle), at which time supernatant was harvested and
stored at 220°C before viral titration on HeLa cells.
Transfection of infectious CVB3-RNA
Total RNA from CVB3-infected HeLa cells (6 h p.i.) was
prepared with TRIZOL and transfected into cells using
LipoFECTIN Reagent (GIBCO BRL) and the conditions
recommended by the manufacturer. tRNA was used to
keep the total amount of RNA transfected constant (5
mg/well). The efficiency with which the transfected RNA
yielded infectious CVB3 was titrated by transfecting se-
rial dilutions of RNA into HeLa cells and then treating as
for a standard plaque assay (covering with agarose/
DMEM etc.) and was found to be ;104 PFU/mg. Mono-
ayers of the different cell lines, 70–80% confluent, were
ransfected with the indicated dilutions of infectious RNA
or mock transfected with tRNA) and incubated for 10 h,
nd then supernatants were collected and titrated by
laque assay as above.ISH
We followed a published protocol (Cao et al., 1995),
ith some modifications. Cells were incubated with CVB
m.o.i. 5 ;10) or mock infected. Then 6 h later, the cells
ere washed once with saline, trypsinized, transferred to
5-ml conical tubes, and washed once with complete
MEM and once with HH buffer (13 Hanks’ balanced
alt solution, 20 mM HEPES, pH 7.2). Cells were then
esuspended in 400 ml of HH by gentle pipetting, trans-
erred to 1.5-ml microfuge tubes, and fixed by the addition
f 45 ml of 10% NBF. After a 5-min incubation at room
emperature, cells were spun at 300 g for 5 min, washed
nce with HH, and resuspended in 300 ml of HH. To this
olution, 0.7 ml of absolute ethanol was added, and the
ells were stored at 220°C until analyzed. Then 5 3 105
cells (at a concentration of 3 3 106 cells/ml) were treated
ith 1 ml of 10% DEPC in ethanol/50 ml of cell suspension
for 15 min at room temperature to block endogenous
RNase activity. Cells were then spun as above and incu-
bated in HH buffer with 0.5% Tween 20 (buffer HH-T) for
5 min at room temperature. One volume of 203 SSC and
2 volumes of formamide were added to this solution.
Cells were spun and resuspended in 10 ml of prewarmed
hybridization buffer (53 SSC, 50% formamide, 0.1% SDS,
and 500 mg/ml tRNA) containing ;1 ng of the biotinyl-
ted RNA probe. Cells were incubated overnight at 45°C
ith rotation and then washed with 100 ml of prewarmed
hybridization buffer (without probe) for 45 min at 45°C
with rotation, centrifuged, and resuspended in pre-
warmed 0.13 SSC and 0.1% SDS for 30 min at 45°C. After
centrifugation, cells were resuspended in 50 ml of 5
mg/ml streptavidin-phycoerythrin (PharMingen, San Di-
ego, CA) in HH-T, incubated for 30 min at 45°C, and then
washed with 400 ml of HH-T containing 0.13 SSC and
0.1% SDS for 2 min at 45°C. Cells were finally resus-
pended in 200 ml of HH-T and analyzed on an FACscan
flow cytometer. Data were analyzed with CellQuest soft-
ware (Becton-Dickinson, Franklin Lakes, NJ).
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